credit card approval
Scope
Date
~
-
Woori Financial wins approval for Tongyang, ABL Life acquisition
Woori Financial Group Inc., South Korea’s fourth-largest financial services provider, has received conditional approval from the country&rsquo...
8 HOURS AGO
-
Mergers & Acquisitions
Kyobo Life poised to buy Japan’s SBI Group-owned savings bank
Kyobo Life Insurance Co. is in the final stages of negotiation with Japanese financial group SBI Holdings Inc. to buy about a 50% stake in SBI Savin...
Apr 24, 2025 (Gmt+09:00)
-
Economy
S&P reaffirms South Korea’s AA credit rating with stable outlook
S&P Global Ratings has reaffirmed South Korea’s sovereign credit rating at AA with a stable outlook, citing the country’s resilient ...
Apr 15, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins Australian approval for eye, bone disease biosimilars
Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...
Apr 10, 2025 (Gmt+09:00)
-
Energy
OCI to build $265 mn solar cell plant in Texas, expects $80 mn tax credit
South Korean solar cell company OCI Holdings Co. said on Thursday it will build a solar cell manufacturing plant in Texas through its US subsidiary ...
Mar 20, 2025 (Gmt+09:00)
-
Private equity
Red flags raised even before Homeplus crisis: Sales fall, credit ratings cut
Even before South Korea’s second-largest hypermarket chain Homeplus Co. was put under court receivership due to its worsening financial woes, ...
Mar 18, 2025 (Gmt+09:00)
-
Pension funds
NPS to buy stake in Australia’s Metrics to expand alternative investments
South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, has agreed to buy a stake in Australian asset mana...
Mar 17, 2025 (Gmt+09:00)
-
Bio & Pharma
Samsung, Celltrion lead biosimilar market in Europe, US
Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...
Mar 10, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins EU approval for autoimmune disease treatment Avtozma
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
Feb 25, 2025 (Gmt+09:00)
-
Private equity
Glenwood Credit stresses role as reliable financial partner: CEO Lee
Many companies, big and small, sell or buy affiliated units to raise funds or narrow their focus during economic downturns, and to fund expansion or...
Feb 11, 2025 (Gmt+09:00)
-
Private debt
Real estate debt outshines corporate credit: Savills IM
Private credit has been among the top picks for alternative investors over the past few years. During the period of high interest rates, corporate l...
Jan 14, 2025 (Gmt+09:00)
-
Private equity
Korean lenders to Accell warn they may boycott KKR
KKR & Co. is facing a huge backlash from South Korean financial services firms after the debt restructuring of Dutch bicycle manufacturer Accell...
Jan 10, 2025 (Gmt+09:00)
-
Bio & Pharma
Yuhan’s lung cancer drug gets OK in Europe
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Dec 31, 2024 (Gmt+09:00)
-
Banking & Finance
Lotte Card Card to launch loans for affiliates in Vietnam
South Korea's Lotte Card said on Monday it will launch loans for affiliates in Vietnam.Lotte Finance Vietnam, the Vietnamese corporation of Lotte Ca...
Dec 26, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion obtains approval of Steqeyma from FDA
South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...
Dec 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s 4 new biosimilars win EU approval recommendation
Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...
Dec 16, 2024 (Gmt+09:00)
-
Business & Politics
South Korea’s sovereign credit rating stable: S&P, Moody's, Fitch
South Korea’s sovereign ratings remain stable despite the political turmoil caused by the short-lived martial law declaration of President Yoo...
Dec 13, 2024 (Gmt+09:00)
-
Energy
Korea’s OCI, US partner CPS Energy sign 20-year energy storage deal
South Korean solar cell company OCI Holdings Co. said on Tuesday it has signed a deal with US power supplier CPS Energy to jointly build a 120-megaw...
Dec 10, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets approval of Omlyclo in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...
Dec 09, 2024 (Gmt+09:00)
-
Economy
Korea’s credit fundamentals remain firm amid political crisis: Fitch
South Korea’s credit rating remained unscathed by the political turmoil caused by the short-lived martial law declaration of President Yoon Su...
Dec 06, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
MBK kicks off Lotte Card sale for about $1.4 bn in 2nd bid
Lotte Card Co. is expected to be up for grabs in the first half of next year amid a second sale attempt by its largest shareholder MBK Partners, a N...
Dec 02, 2024 (Gmt+09:00)
-
Airlines
Korean Air gets EU approval for Asiana merger
The European Commission (EC), the European Union (EU) antitrust body, approved the merger between Korean Air Lines Co. and Asiana Airlines Inc. on N...
Nov 29, 2024 (Gmt+09:00)
-
Banking & Finance
KB Kookmin Card, UnionPay to cooperate on marketing
South Korea's KB Kookmin Card said on Tuesday it signed a memorandum of understanding (MOU) with China's UnionPay to cooperate on marketing. ...
Nov 27, 2024 (Gmt+09:00)
-
Travel & Leisure
S.Korean overseas card spending posts record $5.71 bn in Q3
With the increase in international travel during the summer, overseas card spending by South Korean residents reached a record high in the third qua...
Nov 26, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis gets EC's approval for Opuviz
South Korea's Samsung Bioepis Co., Samsung Biologics Co.'s fully owned biosimilar subsidiary, and the US-based Biogen said on Tuesday the European C...
Nov 19, 2024 (Gmt+09:00)
-
Batteries
South Korea approves Korea Zinc’s precursor as national core technology
South Korea has designated Korea Zinc Inc.'s precursor manufacturing process as a national core technology and advanced industrial technology, effec...
Nov 19, 2024 (Gmt+09:00)
-
Corporate bonds
Korea Inc. rushes to booming local corporate bond market
South Korean companies are rushing to raise money in the local corporate bond market, which is unusually buoyant at year's end amid expectations of ...
Nov 18, 2024 (Gmt+09:00)
-
Food & Beverage
Samyang enters Australia, New Zealand with allulose approval
South Korean chemical and food ingredient manufacturer Samyang Corp. said on Wednesday that it has become the first allulose producer to secure appr...
Nov 13, 2024 (Gmt+09:00)
-
Automobiles
Hyundai, Kia gets triple A credit rating from S.Korean agencies
Hyundai Motor Co. and Kia Corp. said on Monday they received AAA ratings, with Stable outlooks for both companies, from Korea Ratings Corp., Nice In...
Nov 04, 2024 (Gmt+09:00)
-
Corporate bonds
S&P upgrades SK Innovation credit rating to BBB-
Global credit rating agency Standard & Poor's (S&P) announced on Friday that it upgraded SK Innovation Co.'s long-term credit rating from a ...
Nov 01, 2024 (Gmt+09:00)
Latest News
- 1 Maybe Happy Ending: How a Seoul-made robot love story rewrote Broadway playbook
- 2 NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen
- 3 Woori Financial wins approval for Tongyang, ABL Life acquisition
- 4 BMW surpasses Mercedes in Korean sales amid imported vehicle market shake-up
- 5 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs